Increasing Colorectal Cancer (CRC) Screening In Primary Care

Status Completed

Clinical Trial Summary

Colorectal cancer screening remains lower than optimal. The purpose of this study was to test the efficacy of phone-based motivational interviewing versus tailored communication versus usual care in increasing CRC screening in primary care clinics.

Clinical Trial Description

Regular screening reduces both morbidity and mortality from colorectal cancer (CRC). Screening rates, however, remain low suggesting the need for innovative research designed to increase screening behavior. The purpose of this study is to compare the effectiveness of two interventions (Tailored Health Communication [THC] and Motivational Interviewing [MI]) in increasing CRC screening behavior. Both interventions are based on a strong conceptual framework derived from the Health Belief Model (HBM) and Transtheoretical Model (TTM), allowing us to explore the underlying mechanisms through which these interventions impact behavior change.

The primary aim of this study is to compare CRC screening test use among 804 participants randomly allocated to control or intervention conditions; participants will be recruited from the two sites (Chicago, IL, and Nashville, TN). The 3 study groups will receive (1) standard care, (2) tailored health communication, and (3) motivational interviewing. Eligibility criteria for study participants includes being 50 years or older, not having CRC, and being of average or moderate risk for CRC. Study participants will be surveyed by telephone about CRC-related beliefs pre-intervention (Time 1), 1 month postintervention (Time 2), and at 6 months postintervention (Times 3 and 4, respectively). Dichotomous behavioral outcomes (had screening test or not) and stages of CRC screening test adoption (based on the TTM) will be assessed, as well as sociodemographic and belief predictors of screening behavior. Binomial and multinomial logistic regression models will be used to evaluate screening test use and stage of test adoption. Sociodemographic and belief variables will be used as covariates, with intervention group as the primary independent predictor. Descriptive statistics and ANOVA will be employed to assess between intervention differences in amenable beliefs. Path (mediation) analysis will be performed to further explore the underlying mechanisms through which THC and MI may differentially affect CRC screening behavior. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01099826
Study type	Interventional
Source	Arizona State University
Contact
Status	Completed
Phase	N/A
Start date	October 2004
Completion date	January 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05929820` - Impact of Protect Your Colon™ on CRC Screening	N/A
Completed	`NCT02754661` - Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.	N/A
Completed	`NCT00955344` - Increasing Primary Care Physician Colorectal Cancer Screening Rates	N/A
Completed	`NCT01141114` - Study of Patient Navigation to Promote Colon Cancer Screening	N/A
Completed	`NCT00503737` - Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates	N/A
Completed	`NCT01250015` - Does Numerical And Pictorial Information On Risk And Benefit Affects The Uptake Of Colorectal Cancer Screening?	N/A
Completed	`NCT04746469` - Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits	N/A
Completed	`NCT03208283` - Evaluation of the Impact of Water Method During Insertion Phase of Flexible Sigmoidoscopy in Training	N/A
Not yet recruiting	`NCT03974542` - Telephone Outreach by Navigators to Improve Repeat Fecal Occult Blood Testing	N/A
Completed	`NCT03176082` - Mailed Reminders Plus Fecal Immunochemical Testing	N/A
Completed	`NCT01210235` - FLU-FIT Program at Kaiser Permanente Northern California	N/A
Completed	`NCT00793455` - Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders	N/A
Active, not recruiting	`NCT04631692` - Evaluating a Health Literacy Intervention to Improve Colorectal Cancer Screening in Underserved Areas	N/A
Completed	`NCT03225560` - Smart Phone App for COLOnoscopic PREParation	N/A
Completed	`NCT01054924` - Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening	N/A
Completed	`NCT00148226` - ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial	Phase 2
Completed	`NCT04131946` - Cancer Screening; Access; Awareness; Navigation	N/A
Recruiting	`NCT05785780` - Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings	N/A
Completed	`NCT04237883` - Primary Care Clinical Excellence Incentive Study	N/A
Not yet recruiting	`NCT06333392` - Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.